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Abstract
Background: Zinc concentrates at excitatory synapses, both at the postsynaptic density and in a subset of
glutamatergic boutons. Zinc can modulate synaptic plasticity, memory formation and nociception by regulating
transmitter receptors and signal transduction pathways. Also, intracellular zinc accumulation is a hallmark of
degenerating neurons in several neurological disorders. To date, no single zinc extrusion mechanism has been
directly localized to synapses. Based on the presence of a canonical PDZ I motif in the Zinc Transporter-1 protein
(ZnT1), we hypothesized that ZnT1 may be targeted to synaptic compartments for local control of cytosolic zinc.
Using our previously developed protocol for the co-localization of reactive zinc and synaptic proteins, we further
asked if ZnT1 expression correlates with presynaptic zinc content in individual synapses.
Findings: Here we demonstrate that ZnT1 is a plasma membrane protein that is enriched in dendritic spines and in
biochemically isolated synaptic membranes. Hippocampal CA1 synapses labelled by postembedding immunogold
showed over a 5-fold increase in ZnT1 concentration at synaptic junctions compared with extrasynaptic membranes.
Subsynaptic analysis revealed a peak ZnT1 density on the postsynaptic side of the synapse, < 10 nm away from the
postsynaptic membrane. ZnT1 was found in the vast majority of excitatory synapses regardless of the presence of
vesicular zinc in presynaptic boutons.
Conclusions: Our study has identified ZnT1 as a novel postsynaptic density protein, and it may help elucidate the role
of zinc homeostasis in synaptic function and disease.
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Background
Homeostasis of ionic or labile zinc (Zn2+) in central neu-
rons might be important in a range of physiological and
pathological events. Zn2+ may act as a co-transmitter at
certain glutamatergic synapses, participate in neuronal sig-
nal transduction, modulate memory formation and noci-
ception, or promote neurodegeneration upon brain insults
[1,2]. Marked differences in the levels of intracellular Zn2+
are found among cellular compartments owing to the co-
ordinated actions of two families of zinc transporter pro-
teins, Slc30a (ZnT1-10) and Slc39 (ZIP1-14). Whereas
ZnTs export Zn2+ away from the cytosol into organelles
or the extracellular space, ZIPs shuttle Zn2+ in opposite
direction [3]. Cytosolic Zn2+ is estimated to be in the
subnanomolar range, but Zn2+ transients in neurons have
been reported following strong depolarization or oxidation
[4]. Accumulation of cytosolic Zn2+ is common in degen-
erating neurons in models of epilepsy, ischemia or Parkin-
son’s disease [5-7]. In contrast, high concentrations of zinc
are normally found at synapses [8]. Bound zinc maintains
the organization of the postsynaptic density (PSD) [9],
where it associates with Shank2/3 protein scaffolds [10]
and SAP-102 [11]. In addition, a subset of excitatory bou-
tons up-take Zn2+ into glutamatergic vesicles via ZnT3
[12]. One may expect, therefore, that specific plasma
membrane proteins support Zn2+ homeostasis at sy-
napses, but their identity remains elusive. One candidate
protein is ZnT1 [13]. ZnT1 localizes to the plasma mem-
brane, reduces cytosolic Zn2+, confers resistance against
Zn2+ toxicity, and it is expressed in several brain regions
[13,14]. We previously developed a protocol that allows
for the co-localization of neuronal proteins and vesicular
Zn2+ by combining immunogold electron microscopy
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with zinc histochemistry [15]. Here we used a similar
approach to ask whether ZnT1 localizes to synapses. We
focused on the CA1 region of the hippocampus because
only half of CA3-to-CA1 synapses contain vesicular Zn2+
[15], allowing for direct comparisons between the pre-
sence of vesicular Zn2+ and ZnT1 expression.
Results and discussion
ZnT1 is found in synaptic regions in hippocampus
Immunostaining for ZnT1 in the CA1 region of the
hippocampus was particularly conspicuous in somata and
apical dendrites of pyramidal cells (Figure 1A), prompting
us to analyze its synaptic distribution. In mature hip-
pocampal cultures (DIV 21), ZnT1 co-localized with
GluR1(+) and SynGAP(+) puncta along dendritic shafts
(Figure 1B), indicating the presence of ZnT1 in spines.
As predicted, ZnT1 appeared as a 55 kDa band in the
cytoplasmic fraction of hippocampal lysates (Figure 1C).
When synaptic and extrasynaptic membranes were se-
parated, ZnT1 was enriched in the synaptic (i.e. Triton-
insoluble and PSD95-rich) plasma membrane fraction
(Figure 1C). The presence of ZnT1 at synapses was inde-
pendently confirmed by mass spectrometry-based analysis
of adult mouse brain synaptosomal fractions (Bayés A,
personal communication).
ZnT1 concentrates at the postsynaptic density
We first established the ultrastructural distribution of
ZnT1 in Lowicryl-embedded CA1 stratum radiatum in
the absence of zinc histochemistry. Postembedding immu-
nogold showed that 80 ± 1% of ZnT1 particles localized to
the plasma membrane, including synaptic junctions,
dendrites, and astrocytes (n = 1,372 gold particles; area
analyzed = 354 μm2; Figures 2A-D). ZnT1 particles often
accumulated at membrane densities of apposed plasma
membranes, including synaptic junctions or presumed
puncta adherentia. Indeed, quantitative analysis revealed
that the ZnT1 surface density was > 5-fold higher in syn-
aptic membranes compared with extrasynaptic mem-
branes in spines, dendritic shafts, or glia (n = 334 particles
over 88.4 μm of membrane; Figure 2E; P < 0.001 for all
comparisons). In the absence of primary antibody, the
density of synaptic particles was markedly lower (0.04 ±
0.03 particles/μm). The small fraction of intracellular
ZnT1 labeling was mainly associated with postsynaptic
membranous material (67 ± 2% of intracellular particles)
(Figure 2A).
Synaptic ZnT1 labeling was widespread, encompassing
76 ± 3% of asymmetric synapses in single ultrathin sections
(3.2 ± 1.7 particles/synapse; range 1–9; n = 175 synapses).
Particle distribution along the axis perpendicular to the
synaptic junction revealed a main peak on the cytoplasmic
side of the postsynaptic membrane (7.1 ± 0.8 nm from the
membrane; n = 339 particles and 132 synapses) (Figure 2F).
Further, tangential analysis of synaptic ZnT1 revealed a
moderate lateral increase along the PSD length (n = 111
particles and 46 synapses; Figure 2G). The results indicate
that ZnT1 concentrates in the postsynaptic membrane of
hippocampal synapses, in keeping with the biochemical
data.
Synaptic ZnT1 expression and vesicular Zn2+
To determine if synaptic ZnT1 expression correlates with
the presence (ZN+) or absence (ZN-) of vesicular Zn2+ in
presynaptic boutons, we performed zinc histochemistry
before tissue embedding. Previous studies have shown that
ZN + synapses selectively co-express the obligatory vesicu-
lar transporter ZnT3, and make up ~45% of axospinous
synapses in CA1 [15]. Indeed, silver granules reporting
vesicular Zn2+ were invariably found in a fraction of bou-
tons and readily distinguished from immunogold particles
(Figure 3A). As earlier, ZnT1 particles were significantly
Figure 1 Synaptic targeting of ZnT1. (A) Bright field immunostaining of ZnT1 in mouse CA1 region. Neuronal perikarya and apical dendrites
(arrowheads) were labeled. s.o. stratum oriens; s.p. stratum piramidale; s.r. stratum radiatum. Scale bar, 100 μm. (B) Confocal images of double
stained dendrites of cultured pyramidal neurons. Scale bar, 5 μm. (C) Left, western blot for ZnT1 in nuclear (N) and cytoplasmic (C) extracts
(20 μg per lane) from adult hippocampus. MW was assessed with biotinylated protein ladder. Right, Synaptic and extrasynaptic fractions (10 μg
per lane) were probed for ZnT1, stripped, and reprobed for actin and PSD-95.
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enriched in synaptic junctions (area analyzed = 316 μm2;
membrane length = 285.4 μm; n = 522 particles; Figure 3C),
and accumulated just inside the postsynaptic membrane
(9.2 ± 1.2 nm; 145 particles; Figure 2F). Synaptic ZnT1 la-
beling was found with similar frequencies at ZN + and
ZN- axospinous synapses in single sections (58 ± 1% of
ZN+ synapses, and 60 ± 3% of ZN- synapses; n = 143
synapses; P = 0.9; Figure 3A, B). Likewise, the number of
synaptic ZnT1 particles was similar between both popu-
lations (2.2 ± 0.2 particles/PSD at ZN+, and 1.5 ± 0.8 par-
ticles/PSD at ZN-; n = 214 particles; P = 0.2). Serial section
analysis confirmed the absence of vesicular Zn2+ in synap-
ses labeled for ZnT1 that had been identified as ZN- in
single sections (n = 51; Figure 3B, right). Moreover, al-
though distal segments of stratum radiatum are known to
stain for Zn2+ more heavily [12], we found similar ZnT1
densities at proximal (< 20 μm from soma) and distal
(> 100 μm away) synapses (n = 103 and 199 synapses,
respectively; P = 0.2). We conclude that postsynaptic
ZnT1 expression does not correlate with vesicular Zn2+
content in individual synapses.
The present results provide compelling evidence that
ZnT1 is preferentially expressed in synaptic membrane
domains in rodent hippocampus (mouse and rat), and
identify ZnT1 as a novel PSD protein. ZnT1 was found
in the somatodendritic compartment in region CA1, it
co-localized with PSD proteins GluR1 and SynGAP in
dendritic spine-like structures, and it was enriched in
synaptic membrane fractions compared with extrasy-
naptic membrane. High-resolution immunogold electron
microscopy confirmed and extended these results, show-
ing that ZnT1 densities were over 5-fold higher in post-
synaptic junction membranes than in other membrane
domains, including extrasynaptic spine membrane, shafts,
boutons, somata or astrocytes. Furthermore, the ZnT1 par-
ticle distribution across the synapse, peaking within 10 nm
Figure 2 Ultrastructural localization of ZnT1. Electron micrographs of Lowicryl sections showing ZnT1 particles (10 nm gold) at synapses
made on dendritic spines (A, C) or shafts (B, D). Particles predominated over synaptic junctions (solid arrowheads). Extrasynaptic labeling was seen
over the plasma membrane of spines and dendrites (white arrowheads). Occasional labeling on extrasynaptic membranes apposed to boutons
(white arrow in D), inside astrocytes (double white arrowhead in C), inside spines (solid arrow in A), or over presynaptic vesicles (double solid
arrowhead in A). b, bouton; s, spine; d, dendrite; a, astrocyte; m, mitochondrion. Scale bars, 0.2 μm. (E) Surface densities of ZnT1 (particles/μm) over
different plasma membranes. (F) Left, Frequency distribution of gold particles across the synaptic junction (i.e. axodendritic). Negative and positive
values denote locations pre- and post-synaptic to the outer leaflet of the postsynaptic membrane, respectively. Distances between the center of gold
particle and membrane were grouped into 5 nm bins. Particles followed a normal distribution with a peak located at the +10 nm bin. Right, Relative
distribution of ZnT1 across the synaptic junction analyzed in Lowicryl and Epon sections. (G) Relative distribution of ZnT1 along the PSD length. Particle
location was computed as a fraction of the distance from the center (0%) to the edge (100%) of the PSD.
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inside the postsynaptic membrane, suggests that ZnT1 is
an integral transmembrane protein at the PSD, which is
consistent with the predicted 6 hydrophobic regions in its
aminoacid sequence [13]. The fact that ZnT1 surface den-
sity was similarly low among several extrasynaptic regions
suggests that, in addition to the secretory pathway tar-
geting ZnT1 to the cell surface, a synapse-specific mecha-
nism may retain ZnT1 at the PSD. One possibility is that
ZnT1 interacts via its cytoplasmic regions with other PSD
proteins to concentrate at synapses. Interestingly, ZnT1 is
the only member of its family that presents a consensus
PDZ Class I motif at its C-terminus (Figure 3D), the latter
showing 100% identity in humans. Several scaffolding mo-
lecules recognize PDZ motifs, including PSD-95, MPP1 or
Lin7. Since the ZnT1 PDZ motif (ESSL) is very similar to
that of GluN2A/B (ESDV), one may speculate that proteins
of the PSD-95 family may also be retaining ZnT1 at the
PSD.
Notably, ZnT1 was not restricted to the subset of
synapses containing vesicular Zn2+. This widespread
distribution implies a general physiological role for
ZnT1 at synapses independently of the actions of ZnT3
or vesicular Zn2+. Accordingly, organizing synaptic scaf-
folds appear particularly sensitive to intracellular Zn2+,
leading to changes in PSD morphology upon zinc chela-
tion [16]. It is therefore possible that zinc status itself af-
fects ZnT1 localization or expression. ZnT1 may be
responsible for counteracting basal ZIP-mediated influx
of interstitial Zn2+ [17] or for removing Zn2+ liberated in
dendrites from redox-sensitive metalloproteins, such as
metallothionein-3 or PKC [18,19]. In keeping with this,
deletion of metallothionein-3 prevents the build-up of
cytosolic Zn2+ following seizures [20]. Additional roles
for ZnT1 besides Zn2+ transport, such as modulation of
MAPK or Ca2+ signaling [21,22], or targeting of poten-
tial PSD protein partners, cannot be ruled out. Genetic
deletion of ZnT1 is embryonic lethal [23]. Given the
high concentration of elemental zinc and ZnT1 at PSDs,
it will be interesting to learn how conditional deletion of
ZnT1 affects synaptic structure and function.
Figure 3 Co-labeling of ZnT1 and vesicular Zn2+. (A) Sections of CA1 synapses stained for vesicular Zn2+ (solid arrows) and ZnT1 (solid arrowheads,
synaptic; white arrowheads, extrasynaptic). (B) ZN- synapses labeled for ZnT1 at the synaptic junction. Right, Consecutive sections of a ZN- axospinous
synapse labeled for ZnT1. b, bouton; s, spine. Scale bars, 0.2 μm. (C) Surface density of gold particles showing the accumulation of ZnT1 in synaptic
junctions (i.e. ZN + and ZN- synapses pooled) compared with various extrasynaptic membrane domains. (D) Sequence analysis of ZnT members showing
that only ZnT1 contains a canonical PDZ type I motif in its C-terminus.
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Conclusion
ZnT1 is the first zinc transporter protein shown to con-
centrate at the PSD. The presence of ZnT1 in the vast
majority of excitatory synapses in hippocampus suggests
an unanticipated basic role for ZnT1 in synaptic func-
tion that warrants further investigation.
Materials and methods
Antibodies
Rabbit anti-ZnT1 antibodies were obtained from William
F. Silverman (Ben-Gurion University). The specificity of
the antibody, raised against the carboxyl-tail of mouse
ZnT1 [14], was previously demonstrated by transfection of
HEK-293 cells with mouse ZnT1 plasmid, and by siRNA-
mediated knockdown in rat cortical neurons [24]. Rabbit
anti-GluR1 antibody, mouse anti-PSD95, and mouse anti-
actin were from Millipore; rabbit anti-SynGAP was from
Affinity Bioreagents.
Immunohistochemistry
All procedures followed present regulations for animal
care and handling and were approved by the University of
Barcelona Ethical Committee. BALB/c mice (2 month-old)
were anesthesized and perfused with heparinized saline,
and 4% formaldehyde/0.1% glutaraldehyde in 0.1 M phos-
phate buffer (PB; pH 7.4). Brains were postfixed for 2 hr,
cryoprotected in 30% sucrose in PB, frozen, and cut into
40 μm-thick sections. Brain slices were freeze-thawed
twice with liquid N2, rinsed in PB, incubated in 0.5%
NaBH4 in PB for 15 min, and blocked in 10% NGS, 1%
BSA and 0.2 M glycine in PBS for 2 hr. Slices were incu-
bated in rabbit anti-ZnT1 antibody (1:500) at 4°C for 2 d,
then rinsed and incubated in biotinylated goat anti-rabbit
IgG (1:200) at 4°C for 8 hr, rinsed again, and incubated in
streptavidin-biotinylated HRP (1:300). The HRP was deve-
loped in 0.05% DAB and 0.001% H2O2 in Tris–HCl
buffer.
Neuronal cultures
Hippocampi were collected from postnatal day 1 pups,
digested with 10 U/ml papain in Hank’s buffer, disso-
ciated, and plated in Neurobasal A with supplements on
poly-D-lysine-coated coverslips. Cultures were fixed with
4% formaldehyde, 4% sucrose in PB, and then 100% me-
thanol for 10 min at 4°C. Tyramide-Cyanine 3 signal
amplification was used according to manufacturer ins-
tructions (Perkin Elmer) to detect binding of anti-GluR1
(1:6,000) or anti-SynGAP (1:8,000) antibodies. Immunola-
beling with anti-ZnT1 antibodies (1:500) was detected
with goat anti-rabbit Alexa488 IgG. Images were captured
using an Olympus Fluoview FV600 confocal microscope
and x63 objectives. Z-series of 4 consecutive optical sec-
tions (0.6 μm) were acquired using sequential scanning
and Kalman filter.
Immunoblotting
Hippocampi were homogenized in 10 volumes of buffer
containing 10 mM HEPES, pH 7.5, 0.32 M sucrose,
2 mM EDTA, 2 mM EGTA, 5 mM DTT, and protease
inhibitor cocktail tablet (Roche), followed by centri-
fugation at 800 g for 10 min. Supernatants were saved as
the cytoplamic fraction. Pellets were resuspended in
homogenization buffer plus 0.5% Nonidet P-40, and cen-
trifuged again to obtain crude nuclear fractions. These
nuclear fractions were resuspended in extraction buffer
containing 10 mM HEPES, pH 7.5, 400 mM NaCl, 10%
glycerol, 0.5% Nonidet P-40, 2 mM EDTA, 2 mM EGTA,
5 mM DTT, and protease inhibitor cocktail. Suspensions
were rocked for 30 min on ice and centrifuged at
16,700 g for 10 min. Resulting supernatants were used
as nuclear extracts. The cytoplasmic fraction was centri-
fuged (10,200 g, 15 min) to obtain the crude synapto-
somal pellet, resuspended with 0.5% Triton, rocked, and
centrifuged at 21,000 g for 40 min. The PSD-enriched
pellet was resuspended in LB. The supernatant containing
non-PSD membranes was precipitated with -20°C acetone.
Equal protein amounts were separated by SDS-PAGE in
8% gels. PVDF membranes were blocked with 5% BSA,
0.1% Tween-20 in Tris-buffered saline (TBS), and incu-
bated overnight at 4°C with ZnT1 antibodies (1:1,000), or
1 h at RT with PSD-95 (1:10,000) or actin (1:5,000) anti-
bodies. Proteins were detected with HRP-conjugated se-
condary antibodies and visualized by chemiluminescence.
Post-embedding immunoelectron microscopy
For acrylic embedding, brains from two Wistar rats (250–
300 g) were perfused with 4% formaldehyde, 0.2% glutaral-
dehyde and 0.2% picric acid in PB, pH 7.4. Vibratome
slices were cryoprotected in glycerol, frozen in liquid pro-
pane, freeze-substituted in 0.5% uranyl acetate in metha-
nol at -90°C, infiltrated with Lowicryl HM20 at -45°C, and
polymerized with UV light. For Zn2+ staining and epoxy
embedding, we used our previous protocol (Sindreu’03).
Briefly, two rats were perfused with 0.1% Na2S and 2.5%
glutaraldehyde in PB, followed by 1% formaldehyde, 2.5%
glutaraldehyde and 0.2% picric acid. Slices were stained
with the Neo-Timm’s method (Danscher, 1981), post-fixed
using an osmium-free protocol (Phend et al., 1995) and
flat-embedded in epoxy resin (Embed-812; EMS). Lowicryl
or epoxy sections (60–70 nm) were collected on gold grids
(200 mesh), incubated in 0.5% NaBH4 in 50 mM Tris-
buffered saline (TBS; pH = 7.6) for 10 min, rinsed in
0.005% Tergitol NP-10 in TBS (TBST), blocked in 10%
NGS, 2% BSA and 50 mM glycine in TBST, and reacted
with anti-ZnT1 antibodies (1:200) overnight. Grids were
rinsed in TBST and TBST/pH 8.2, and incubated in
10 nm gold-conjugated goat anti-rabbit F(ab)2 fragments
(1:30; British BioCell) for 2 h. Grids were rinsed and
counterstained.
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Electron micrographs were taken at × 30,000 magnifica-
tion, recorded by a CCD camera (Gatan Inc.) and analysed
with Canvas software (Deneba Systems, Inc.). The CA1
stratum radiatum was examined by random systematic
sampling of visual fields (1/3) at 10–200 μm from the
pyramidal cell layer. Synapses were defined as those struc-
tures showing synaptic vesicles in the presynaptic element
and a postsynaptic membrane specialization. Labeling at
the synaptic junction was analysed in transversely cut
synaptic profiles. To assess the transversal location of
synaptic gold particles, we measured the distance from the
outer margin of the postsynaptic junctional membrane to
the center of each gold particle in a line perpendicular to
the membrane. Particles were considered ‘synaptic’ when
found within a radius of 30 nm from the postsynaptic
junctional membrane, and ‘extrasynaptic’ when located
further away. Similarly, a 30 nm limit was used to differen-
tiate between surface and intracellular labeling. To assess
the tangential location of particles, the distance of each
gold particle from the centre of the PSD was normalized
to the half-length of the PSD profile. PSD lengths shorter
than 200 nm were excluded for tangential analysis. To cal-
culate the surface density, gold particles in each mem-
brane compartment were counted in digital EM pictures,
and effective membrane lengths measured. Double stain-
ing for vesicular Zn2+ and ZnT1 was studied in synapses
located within 4 μm from the net surface of the vibratome
slice to avoid false negative counts [15]. T-test and
ANOVA were used for pair-wise and multiple compari-
sons, respectively. Significance was set at 0.05. Data are
given as mean ± standard error of mean unless otherwise
noted.
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